BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4050592)

  • 41. Manipulating systemic and mucosal immune responses with skin-deliverable adjuvants.
    Chin J; San Gil F; Novak M; Eamens G; Djordjevic S; Simecka J; Duncan J; Mullbacher A
    J Biotechnol; 1996 Jan; 44(1-3):13-9. PubMed ID: 8717381
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting of mucosal vaccines to Peyer's patch M cells.
    Frey A; Neutra MR
    Behring Inst Mitt; 1997 Feb; (98):376-89. PubMed ID: 9382762
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluorescence microscopy and flow cytometric analysis of Peyer's patches and intestinal immune cells.
    López MC
    Curr Protoc Toxicol; 2007 Aug; Chapter 18():Unit18.13. PubMed ID: 23045140
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Strong mucosal adjuvanticity of cholera toxin within lipid particles of a new multiple emulsion delivery system for oral immunization.
    Tomasi M; Dertzbaugh MT; Hearn T; Hunter RL; Elson CO
    Eur J Immunol; 1997 Oct; 27(10):2720-5. PubMed ID: 9368632
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced mucosal priming by cholera toxin and procholeragenoid with a lipoidal amine adjuvant (avridine) delivered in liposomes.
    Pierce NF; Sacci JB
    Infect Immun; 1984 May; 44(2):469-73. PubMed ID: 6370867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impaired B cell responses to orally administered antigens in lamina propria but not Peyer's patches of Galphai2-deficient mice prior to colitis.
    Ohman L; Aström RG; Hultgren Hörnquist E
    Immunology; 2005 Jun; 115(2):271-8. PubMed ID: 15885134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues.
    Xu-Amano J; Kiyono H; Jackson RJ; Staats HF; Fujihashi K; Burrows PD; Elson CO; Pillai S; McGhee JR
    J Exp Med; 1993 Oct; 178(4):1309-20. PubMed ID: 8376936
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rabbit ileal lamina propria (LP) lymphocytes give poor blastogenic responses to KLH immunization and concanavalin A mitogenesis.
    Brewer TG; Reid RH; Hooper CA; McCarthy WT
    Adv Exp Med Biol; 1987; 216A():497-504. PubMed ID: 3687536
    [No Abstract]   [Full Text] [Related]  

  • 49. Arginine enhances induction of T helper 1 and T helper 2 cytokine synthesis by Peyer's patch alpha beta T cells and antigen-specific mucosal immune response.
    Kobayashi T; Yamamoto M; Hiroi T; McGhee J; Takeshita Y; Kiyono H
    Biosci Biotechnol Biochem; 1998 Dec; 62(12):2334-40. PubMed ID: 9972259
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral vaccine models: multiple delivery systems employing tetanus toxoid.
    Jackson RJ; Staats HF; Xu-Amano J; Takahashi I; Kiyono H; Hudson ME; Gilley RM; Chatfield SN; McGhee JR
    Ann N Y Acad Sci; 1994 Aug; 730():217-34. PubMed ID: 8080173
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Affecting the effectors: a kick in the gut?
    Johansson C; Kelsall BL
    Nat Immunol; 2005 Jul; 6(7):644-6. PubMed ID: 15970934
    [No Abstract]   [Full Text] [Related]  

  • 52. Intraduodenal application of cholera holotoxin increases the potential of clones from Peyer's patch B cells of relevant and unrelated specificities to secrete IgG and IgA.
    Lebman DA; Fuhrman JA; Cebra JJ
    Reg Immunol; 1988; 1(1):32-40. PubMed ID: 3275128
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of a combined mucosal and systemic anti-ovalbumin response.
    Bianchi AT; Zwart RJ; van der Heijden PJ
    Adv Exp Med Biol; 1988; 237():675-80. PubMed ID: 3254069
    [No Abstract]   [Full Text] [Related]  

  • 54. Cellular and molecular biologic approaches for analyzing the in vivo development and maintenance of gut mucosal IgA responses.
    Cebra JJ; Bos NA; Cebra ER; Kramer DR; Kroese FG; Schrader CE
    Adv Exp Med Biol; 1995; 371A():429-34. PubMed ID: 8525959
    [No Abstract]   [Full Text] [Related]  

  • 55. Modulation of human enteric epithelial barrier and ion transport function by Peyer's patch lymphocytes.
    Chen J; Tsang LL; Ho LS; Rowlands DK; Gao JY; Ng CP; Chung YW; Chan HC
    World J Gastroenterol; 2004 Jun; 10(11):1594-9. PubMed ID: 15162532
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The influence of Peyer's patch apoptosis on intestinal mucosal immunity in burned mice.
    Fan J; Xie Y; Li X; Guo G; Meng Q; Xiu Y; Li T; Feng W; Ma L
    Burns; 2009 Aug; 35(5):687-94. PubMed ID: 19269747
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peyer's patches: organized lymphoid structures for the induction of mucosal immune responses in the intestine.
    Makala LH; Suzuki N; Nagasawa H
    Pathobiology; 2002-2003; 70(2):55-68. PubMed ID: 12476030
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural and functional differences between putative mucosal inductive sites of the rat.
    Zuercher AW; Cebra JJ
    Eur J Immunol; 2002 Nov; 32(11):3191-6. PubMed ID: 12555664
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systemic and mucosal immunity induced by attenuated Salmonella enterica serovar Typhimurium expressing ORF7 of porcine reproductive and respiratory syndrome virus.
    Han YW; Kim SB; Rahman M; Uyangaa E; Lee BM; Kim JH; Park KI; Hong JT; Han SB; Eo SK
    Comp Immunol Microbiol Infect Dis; 2011 Jul; 34(4):335-45. PubMed ID: 21543119
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reovirus serotype 1/strain Lang-stimulated activation of antigen-specific T lymphocytes in Peyer's patches and distal gut-mucosal sites: activation status and cytotoxic mechanisms.
    Bharhani MS; Grewal JS; Pilgrim MJ; Enocksen C; Peppler R; London L; London SD
    J Immunol; 2005 Mar; 174(6):3580-9. PubMed ID: 15749895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.